ArticleTuberculosis (Edinburgh, Scotland)2023

Microbiological profile, preclinical pharmacokinetics and efficacy of CRS0393, a novel antimycobacterial agent targeting MmpL3.

Urs A Ochsner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.